大直径大隐静脉:氰基丙烯酸酯闭合联合高位结扎与单纯闭合的长期结局比较
单中心回顾性队列研究纳入2018至2022年198条术前大隐静脉直径≥8 mm的症状性功能不全患肢,比较单纯氰基丙烯酸酯闭合(CAC)与高位结扎联合CAC(HSL+CAC)的长期结局。HSL+CAC组大隐静脉闭塞率更高、隐股交界反流更少、术后VCSS更低且改善更大,再手术率更低,并发症率两组均低且相似。
要点
- 大直径大隐静脉中HSL+CAC的长期闭塞率与临床改善优于单纯CAC。
- HSL+CAC组隐股交界反流显著更少,再手术率为零。
- 两组并发症率均低且相似,联合术式未明显增加并发症。
核心结论
- 在大直径大隐静脉中,HSL+CAC与优于单纯CAC的长期解剖和临床结局相关,且并发症无明显增加。
- 研究提示对选定的大直径大隐静脉患者,在CAC基础上加做高位结扎可能改善长期结局。
研究设计与样本
- 单中心回顾性队列研究,评估2018年1月至2022年12月间180例患者共198条因症状性大隐静脉功能不全接受治疗的患肢,术前大隐静脉直径≥8 mm。
- CAC组127条患肢,HSL+CAC组71条患肢;采用广义估计方程(GEE)模型校正患者内聚集和预设混杂因素,并以倾向评分重叠权重(PSOW)作敏感性分析。
- 长期双功超声随访数据可得186条患肢(93.9%)。
主要发现
- HSL+CAC组大隐静脉闭塞率84.1% vs 65.8%(P = .007)。
- HSL+CAC组隐股交界反流5.8% vs 47.0%(P < .001)。
- HSL+CAC组术后静脉临床严重程度评分(VCSS)2.45 ± 2.04 vs 3.15 ± 1.89(P = .019),VCSS改善3.45 ± 2.21 vs 1.47 ± 1.93(P < .001)。
- 单纯CAC组再手术率8.7%,HSL+CAC组为0(P = .008)。
- 校正GEE分析中,HSL+CAC与更低的术后VCSS相关(β,-1.15;95% CI,-1.71至-0.59),与大隐静脉闭塞相关(OR,3.05;95% CI,1.31-7.14),与更少的隐股交界反流相关(OR,0.06;95% CI,0.015-0.223);PSOW估计与主分析一致。
关键数值与推荐
- 纳入标准为症状性大隐静脉功能不全且术前大隐静脉直径≥8 mm。
- 主要比较指标包括长期双功超声大隐静脉闭塞、隐股交界反流、术后VCSS及VCSS改善、再手术率和并发症率。
临床怎么用
- 对术前大隐静脉直径≥8 mm的症状性功能不全患者,可考虑在CAC基础上加做高位结扎以改善长期解剖和临床结局。
- 决策时需结合患者个体情况,因本研究为单中心回顾性设计,联合术式的获益尚需进一步验证。
局限性
- 单中心回顾性队列研究,存在选择偏倚可能。
- 长期双功超声随访数据可得186条患肢(93.9%),存在随访缺失。
- 研究结果需在更多人群和前瞻性设计中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
J Vasc Surg Venous Lymphat Disord . 2026 Oct 28:102649. doi: 10.1016/j.jvsv.2026.102649. Online ahead of print. ABSTRACT OBJECTIVE: Long-term evidence regarding the effectiveness of cyanoacrylate closure (CAC) in large-diameter great saphenous veins (GSVs) is limited. This study aimed to compare the long-term outcomes of CAC alone with those of combined high saphenous ligation and cyanoacrylate closure (HSL + CAC) for large-diameter GSV insufficiency. METHODS: This single-center retrospective cohort study evaluated 198 extremities in 180 patients treated for symptomatic GSV insufficiency between January 2018 and December 2022 who had a preoperative GSV diameter of ≥8 mm. CAC was performed in 127 extremities and HSL + CAC in 71. Clinical and long-term duplex outcomes were compared using generalized estimating equation (GEE) models that accounted for within-patient clustering and prespecified confounders. Propensity score overlap weighting (PSOW) was used as a sensitivity analysis. RESULTS: Long-term duplex follow-up data were available for 186 extremities (93.9%). HSL + CAC was associated with greater GSV occlusion (84.1% vs 65.8%; P = .007), less saphenofemoral junction (SFJ) reflux (5.8% vs 47.0%; P < .001), a lower postoperative Venous Clinical Severity Score (VCSS; 2.45 ± 2.04 vs 3.15 ± 1.89; P = .019), and greater VCSS improvement (3.45 ± 2.21 vs 1.47 ± 1.93; P < .001). Reoperation was performed in 8.7% of extremities treated with CAC alone but in none treated with HSL + CAC (P = .008). In adjusted GEE analyses, HSL + CAC was associated with a lower postoperative VCSS (β, -1.15; 95% CI, -1.71 to -0.59), greater GSV occlusion (OR, 3.05; 95% CI, 1.31-7.14), and less SFJ reflux (OR, 0.06; 95% CI, 0.015-0.223). PSOW estimates were consistent with the primary analyses. Complication rates were low and similar in both groups. CONCLUSIONS: In large-diameter GSVs, HSL + CAC was associated with better long-term anatomic and clinical outcomes than CAC alone, without an appreciable increase in complications. These findings suggest that adding HSL to CAC may improve long-term outcomes in selected patients with large-diameter GSVs. PMID: 42950953 | DOI: 10.1016/j.jvsv.2026.102649
引用
- PubMed · J Vasc Surg Venous Lymphat Disord:Long-term outcomes of cyanoacrylate closure alone versus combined high saphenous ligation and cyanoacrylate closure in large-diameter great saphenous veins
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。